Laird Superfood, Inc.
LSF NYSE Food And Kindred Products Financials FY2019βFY2025
What Laird Superfood, Inc. does
No business description yet.
- Legal name
- Laird Superfood, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 30, 2026
- Accession Β· CIK
- 0001437749-26-010369
0001650696
Revenue and margins
Laird Superfood, Inc. had $49.9M of revenue in fiscal 2025, up 15.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$2.9M in fiscal 2025, β5.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Laird Superfood, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Laird Superfood, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $31.6M | $17.3M | $7.6M | $8.3M | $5.1M |
| Current ratio | 12.6x | 3.7x | 3.7x | 3.0x | 2.4x |
| Quick ratio | 9.9x | 2.9x | 2.3x | 2.0x | 1.4x |
| Total assets | $65.8M | $30.0M | $18.0M | $19.3M | $19.2M |
| Total liabilities | $3.8M | $7.5M | $4.6M | $6.1M | $7.8M |
| Shareholders' equity | $62.1M | $22.5M | $13.4M | $13.2M | $11.5M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 8 | 3 / 8 | 2 / 8 | 4 / 7 | 5 / 7 | 2 / 7 |
| Accruals ratio | 5.7% | 3.7% | β2.4% | β54.3% | 2.5% | β14.4% | β2.4% |
| Altman Z'' | 1.47 | 33.41 | 16.34 | β11.94 | β15.80 | β12.67 | β14.73 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $13.1M | $25.8M | $36.8M | $35.8M | $34.2M | $43.3M | $49.9M |
| Gross profit | $5.1M | $6.6M | $9.4M | $5.2M | $10.3M | $17.7M | $18.9M |
| Research and development | $0.3M | $0.5M | $1.0M | $0.4M | $0.2M | $0.1M | $0.3M |
| Operating income | β$8.8M | β$12.9M | β$24.0M | β$40.4M | β$10.7M | β$2.2M | β$3.4M |
| Interest expense | $0.0M | $0.0M | β | β | β | β | β |
| Pretax income | β$8.5M | β$12.9M | β$23.9M | β$40.3M | β$10.1M | β$1.8M | β$3.2M |
| Income tax | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M |
| Net income | β$8.5M | β$12.9M | β$23.9M | β$40.3M | β$10.2M | β$1.8M | β$3.3M |
| Net income to common | β$1.1M | β$14.5M | β$23.9M | β$40.3M | β | β | β |
| Diluted EPS | β$0.29 | β$2.61 | β$2.66 | β$4.41 | β$1.09 | β | β |
| Diluted shares | 0.00B | 0.01B | 0.01B | 0.01B | β | β | β |
| Cash flow | |||||||
| Cash from operations | β$9.4M | β$14.7M | β$22.1M | β$14.3M | β$10.8M | $0.9M | β$2.8M |
| Capital expenditure | $2.4M | $1.1M | $1.6M | $1.2M | $0.1M | $0.0M | $0.1M |
| Free cash flow | β$11.9M | β$15.7M | β$23.7M | β$15.5M | β$10.9M | $0.8M | β$2.9M |
| Depreciation and amortization | $0.3M | $0.5M | $1.0M | $1.1M | $0.3M | $0.3M | $0.3M |
| Stock-based compensation | $0.7M | $1.4M | $3.6M | $0.6M | $1.1M | $1.6M | $1.9M |
| Share buybacks | $1.1M | $0.0M | $0.0M | β | β | β | β |
| Dividends and buybacks | $1.1M | $0.0M | $0.0M | β | β | β | β |
| Balance sheet | |||||||
| Cash and short-term investments | $6.5M | $65.7M | $31.6M | $17.3M | $7.6M | $8.3M | $5.1M |
| Total debt | β | $0.1M | β | β | β | β | β |
| Current assets | $10.0M | $76.0M | $47.7M | $27.5M | $16.3M | $18.0M | $18.8M |
| Current liabilities | $1.5M | $2.7M | $3.8M | $7.5M | $4.4M | $5.9M | $7.7M |
| Inventory | $2.4M | $6.3M | $10.2M | $5.7M | $6.3M | $6.0M | $7.8M |
| Property and equipment, net | $3.2M | $3.5M | $4.5M | $0.2M | $0.1M | $0.1M | $0.0M |
| Goodwill | β | $0.0M | $6.5M | $0.0M | $0.0M | β | $0.0M |
| Intangible assets | β | $0.1M | $4.8M | $1.4M | $1.2M | $1.0M | $0.2M |
| Total assets | $16.4M | $82.3M | $65.8M | $30.0M | $18.0M | $19.3M | $19.2M |
| Total liabilities | $1.6M | $2.8M | $3.8M | $7.5M | $4.6M | $6.1M | $7.8M |
| Preferred stock | $6.7M | β | β | β | β | β | β |
| Shareholders' equity | $8.1M | $79.5M | $62.1M | $22.5M | $13.4M | $13.2M | $11.5M |
| Margins | |||||||
| Gross margin | 38.8% | 25.5% | 25.6% | 14.5% | 30.1% | 40.9% | 37.9% |
| Operating margin | β66.8% | β50.1% | β65.1% | β112.7% | β31.3% | β5.0% | β6.8% |
| EBITDA margin | β64.5% | β48.3% | β62.4% | β109.5% | β30.4% | β4.4% | β6.3% |
| Net margin | β64.9% | β49.8% | β64.8% | β112.6% | β29.7% | β4.2% | β6.5% |
| FCF margin | β90.5% | β61.1% | β64.3% | β43.2% | β31.9% | 1.9% | β5.7% |
| Returns | |||||||
| Return on capital | β | β73.4% | β | β | β | β | β |
| Return on capital employed | β58.8% | β16.2% | β38.6% | β178.7% | β78.3% | β16.3% | β29.7% |
| Return on equity | β104.8% | β29.3% | β33.7% | β95.4% | β56.6% | β13.7% | β26.4% |
| Return on assets | β51.8% | β26.0% | β32.2% | β84.1% | β42.3% | β9.8% | β16.9% |
| Return on tangible equity | β13.0% | β18.3% | β47.1% | β191.3% | β83.3% | β15.0% | β28.9% |
| Growth | |||||||
| Revenue growth | β | 96.8% | 42.8% | β2.7% | β4.5% | 26.5% | 15.2% |
| FCF growth | β | β | β | β | β | β | β440.4% |
| Share count change | β | 51.2% | 62.0% | 1.8% | β | β | β |
| Financial health | |||||||
| Debt / equity | β | 0.0x | β | β | β | β | β |
| Interest coverage | β179.3x | β | β | β | β | β | β |
| Current ratio | 6.6x | 27.7x | 12.6x | 3.7x | 3.7x | 3.0x | 2.4x |
| Quick ratio | 5.0x | 25.4x | 9.9x | 2.9x | 2.3x | 2.0x | 1.4x |
| Capital allocation | |||||||
| Capex / revenue | 18.5% | 4.1% | 4.2% | 3.2% | 0.4% | 0.1% | 0.2% |
| Stock comp / revenue | 5.3% | 5.5% | 9.7% | 1.8% | 3.2% | 3.8% | 3.8% |
| Quality scores | |||||||
| Piotroski F-score | β | 2.0 | 3.0 | 2.0 | 4.0 | 5.0 | 2.0 |
| Altman Z'' | 1.5 | 33.4 | 16.3 | β11.9 | β15.8 | β12.7 | β14.7 |
| Accruals ratio | 5.7% | 3.7% | β2.4% | β54.3% | 2.5% | β14.4% | β2.4% |
Source: SEC EDGAR XBRL filings (CIK 0001650696). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.